(Q42491380)

1 November 2017

title

Modulatory effects of atorvastatin on endothelial cell-derived chemokines, cytokines, and angiogenic factors (English)

1 reference

1 November 2017

0 references

Issam Zineh

1

1 reference

1 November 2017

Xiaoping Luo

2

1 reference

1 November 2017

Gregory J Welder

3

1 reference

1 November 2017

Amy E Debella

4

1 reference

1 November 2017

Timothy R Wessel

5

1 reference

1 November 2017

Christopher B Arant

6

1 reference

1 November 2017

Richard S Schofield

7

1 reference

1 November 2017

Nasser Chegini

8

1 reference

1 November 2017

language of work or name

English

0 references

publication date

1 March 2006

1 reference

1 November 2017

1 reference

1 November 2017

volume

26

1 reference

1 November 2017

issue

3

1 reference

1 November 2017

page(s)

333-340

1 reference

Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm

1 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.3.333

Regulation of chemokine expression in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.3.333

Atherosclerosis — An Inflammatory Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.3.333

Immune mechanisms in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.3.333

Inflammation in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.3.333

Human endothelium as a source of multifunctional cytokines: molecular regulation and possible role in human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.3.333

Statins do more than just lower cholesterol

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.3.333

Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.3.333

Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.3.333

High-dose atorvastatin enhances the decline in inflammatory markers in patients with acute coronary syndromes in the MIRACL study

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.3.333

Inhibitory effect of pitavastatin (NK-104) on the C-reactive-protein-induced interleukin-8 production in human aortic endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.3.333

Regulation of interleukin-8 expression by HMG-CoA reductase inhibitors in human vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.3.333

Pravastatin suppresses the interleukin-8 production induced by thrombin in human aortic endothelial cells cultured with high glucose by inhibiting the p44/42 mitogen activated protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.3.333

HMG-CoA reductase inhibitor, fluvastatin, has cholesterol-lowering independent "direct" effects on atherosclerotic vessels in high cholesterol diet-fed rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.3.333

Statins (HMG-CoA reductase inhibitors) reduce CD40 expression in human vascular cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.3.333

Low-level endotoxin induces potent inflammatory activation of human blood vessels: inhibition by statins

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.3.333

The effect of statins on mRNA levels of genes related to inflammation, coagulation, and vascular constriction in HUVEC. Human umbilical vein endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.3.333

Simvastatin reduces the expression of adhesion molecules in circulating monocytes from hypercholesterolemic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.3.333

Hydroxymethylglutaryl coenzyme a reductase inhibitors down-regulate chemokines and chemokine receptors in patients with coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.3.333

Hydroxymethylglutaryl coenzyme A reductase inhibitors modify the inflammatory response of human macrophages and endothelial cells infected with Chlamydia pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.3.333

Stimulation of inflammatory responses in vitro and in vivo by lipophilic HMG-CoA reductase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.3.333

Markers of inflammation and their clinical significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.3.333

Structure and neutrophil-activating properties of a novel inflammatory peptide (ENA-78) with homology to interleukin 8

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.3.333

Statins decrease Toll-like receptor 4 expression and downstream signaling in human CD14+ monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.3.333

Changes in serum interleukin-6 and high-sensitivity C-reactive protein levels in patients with acute coronary syndrome and their responses to simvastatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.3.333

Atorvastatin reduces proinflammatory markers in hypercholesterolemic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.3.333

Early vascular benefits of statin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.3.333

The heparin-binding (fibroblast) growth factor family of proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.3.333

Clinical applications of granulocyte colony stimulating factor (G-CSF)

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.3.333

New insights into the pharmacodynamic and pharmacokinetic properties of statins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.3.333

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.3.333

Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.3.333

21 January 2018

Identifiers

DOI

10.1592/PHCO.26.3.333

1 reference

1 November 2017

1 reference